UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 491

Sortiert nach

Prevalence of hepatitis B virus in primary central nervous system lymphoma

Journal of neuro-oncology, 2015-10, Vol.125 (1), p.219-221

2015

Link zum Volltext

Verfügbarkeit prüfen

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (8), p.2543-2557

2021

Link zum Volltext

Verfügbarkeit prüfen

Input of molecular analysis in medical management of primary brain tumor patients

Revue neurologique, 2015-06, Vol.171 (6-7), p.457-465

2015

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

CPT: pharmacometrics and systems pharmacology, 2015-12, Vol.4 (12), p.728-737

2015

Link zum Volltext

Verfügbarkeit prüfen

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii39-ii40

2014

Link zum Volltext

Verfügbarkeit prüfen

P17.08 RENAL THROMBOTIC MICROANGIOPATHY INDUCED BY BEVACIZUMAB IN HIGH GRADE GLIOMA PATIENTS - ABOUT SIX CASES

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii88-ii88

2014

Link zum Volltext

Verfügbarkeit prüfen

Mixed histiocytosis, a rare cause of stroke

Revue neurologique, 2015-09, Vol.171 (8-9), p.676

2015

Link zum Volltext

Verfügbarkeit prüfen

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy

Journal of neuro-oncology, 2013-11, Vol.115 (2), p.261-265

2013

Link zum Volltext

Verfügbarkeit prüfen

Foreword

Revue neurologique, 2023-06, Vol.179 (5), p.377

2023

Link zum Volltext

Verfügbarkeit prüfen

Foreword

Revue neurologique, 2023-06, Vol.179 (5), p.377-377

2023

Link zum Volltext

Verfügbarkeit prüfen

P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii86-ii87

2014

Link zum Volltext

Verfügbarkeit prüfen

O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii23-ii23

2014

Link zum Volltext

Verfügbarkeit prüfen

Severe COVID-19-related encephalitis can respond to immunotherapy

Brain (London, England : 1878), 2020-12, Vol.143 (12), p.e102-e102

2020

Link zum Volltext

Verfügbarkeit prüfen

TP53 codon 72 polymorphism is associated with age at onset of glioblastoma

Neurology, 2009-01, Vol.72 (4), p.332

2009

Link zum Volltext

Verfügbarkeit prüfen

802 ORAL Epigenetic Markers Identify MGMT-methylated Glioblastoma Poorly Responding to Combined Radiotherapy-temozolomide (Stupp Regimen)

European journal of cancer (1990), 2011, Vol.47, p.S95-S95

2011

Link zum Volltext

Verfügbarkeit prüfen

P20.04.B DIAGNOSIS AND TREATMENT OF PERIPHERAL AND CRANIAL NERVE TUMORS WITH EXPERT RECOMMENDATIONS: AN EUROPEAN NETWORK FOR RARE CANCERS (EURACAN) INITIATIVE

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii127-ii127

2023

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy in central neurocytoma and review of literature

Cancer radiothérapie, 2014-06, Vol.18 (3), p.222-8; quiz 245

2014

Link zum Volltext

Verfügbarkeit prüfen

Nutritional status in patients with recurrent glioblastoma

Revue neurologique, 2013-11, Vol.169 (11), p.892-897

2013

Link zum Volltext

Verfügbarkeit prüfen

Évaluation du statut nutritionnel chez les patients présentant un glioblastome en récidive

Revue neurologique, 2013-11, Vol.169 (11), p.892-897

2013

Link zum Volltext

Verfügbarkeit prüfen

Place de la radiothérapie dans les neurocytomes centraux et revue de la littérature

Cancer radiothérapie, 2014-06, Vol.18 (3), p.222-228

2014

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

Neuropathology and applied neurobiology, 2009-04, Vol.35 (2), p.208-213

2009

Link zum Volltext

Verfügbarkeit prüfen

Gliomes de bas grade : quand proposer un traitement médical et pourquoi ?

Revue neurologique, 2013-04, Vol.169, p.A208-A208

Idbaih, A.

2013

Link zum Volltext

Verfügbarkeit prüfen

292P Androgen receptor signalling is associated with resistance to temozolomide and tumour growth in glioblastoma

Annals of oncology, 2022-09, Vol.33, p.S672

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications

Critical care medicine, 2023-04, Vol.51 (4), p.e101

2023

Link zum Volltext

Verfügbarkeit prüfen

Ouverture de la barrière hémato-encéphalique par un dispositif ultrasonore implantable : résultats pré-cliniques sur primates et résultats préliminaires de l’essai clinique SonoCloud de phase I/Iia

Neuro-chirurgie, 2014-12, Vol.60 (6), p.329-329

2014

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 491

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(466)
Mit Volltextzugriff
(454)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Prevalence of hepatitis B virus in primary central nervous system lymphoma

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

Input of molecular analysis in medical management of primary brain tumor patients

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM

P17.08 RENAL THROMBOTIC MICROANGIOPATHY INDUCED BY BEVACIZUMAB IN HIGH GRADE GLIOMA PATIENTS - ABOUT SIX CASES

Mixed histiocytosis, a rare cause of stroke

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy

Foreword

Foreword

P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY

O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS

Severe COVID-19-related encephalitis can respond to immunotherapy

TP53 codon 72 polymorphism is associated with age at onset of glioblastoma

802 ORAL Epigenetic Markers Identify MGMT-methylated Glioblastoma Poorly Responding to Combined Radiotherapy-temozolomide (Stupp Regimen)

P20.04.B DIAGNOSIS AND TREATMENT OF PERIPHERAL AND CRANIAL NERVE TUMORS WITH EXPERT RECOMMENDATIONS: AN EUROPEAN NETWORK FOR RARE CANCERS (EURACAN) INITIATIVE

Radiotherapy in central neurocytoma and review of literature

Nutritional status in patients with recurrent glioblastoma

Évaluation du statut nutritionnel chez les patients présentant un glioblastome en récidive

Place de la radiothérapie dans les neurocytomes centraux et revue de la littérature

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

Gliomes de bas grade : quand proposer un traitement médical et pourquoi ?

292P Androgen receptor signalling is associated with resistance to temozolomide and tumour growth in glioblastoma

Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications

Ouverture de la barrière hémato-encéphalique par un dispositif ultrasonore implantable : résultats pré-cliniques sur primates et résultats préliminaires de l’essai clinique SonoCloud de phase I/Iia

Aktive Filter

Suchergebnisse filtern